DRTS - MCAP CO - Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd. (DRTS) requires constant development investment, as it lacks a stable cash flow due to the early stage of product implementation. At the same time, the company possesses significant market influence in the radiation therapy segment thanks to the uniqueness of the Alpha DaRT method. This daily price chart for the asset with a capitalization of 1.35 clearly illustrates the asset's dynamics. The issuer's revenues will be based on the sale of advanced systems for the targeted delivery of isotopes to neoplasms.

Market capitalization is the product of the current share price and the total volume of shares outstanding. Investors use this aggregate to assess the scale of a business and determine the risk level during price volatility. By analyzing the market capitalization of a company on GURU.Markets, one can track an asset's resilience to market trends. For Alpha Tau Medical Ltd. (DRTS), this metric reflects the valuation of the potential of their unique alpha-therapy tumor system. A high valuation scale confirms market confidence in the implementation of innovations within surgical oncology.